Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 7Breast Neoplasms 4Lung Neoplasms 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Colorectal Neoplasms 2Uveal Melanoma 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Substance-Related Disorders 1Smoking 1Patient Acceptance of Health Care 1Motor Activity 1Lymphoma 1Lung Cancer Screening 1Leukemia 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Depression 1Death 1Central Nervous System Neoplasms 1Carcinoma, Transitional Cell 1Cancer Patients 1Acquired Immunodeficiency Syndrome 1

Interventions

Fluorouracil 9Oxaliplatin 7Leucovorin 7Surveys and Questionnaires 6Blood Specimen Collection 6Bevacizumab 6Specimen Handling 5Gemcitabine 5Cetuximab 5Capecitabine 5fludarabine 4aldesleukin 4Standard of Care 4Irinotecan 4Cyclophosphamide 4Remote Patient Monitoring 3Radiosurgery 3Pafolacianine 3Nivolumab 3Endoscopic Mucosal Resection 3Cisplatin 3130-nm albumin-bound paclitaxel 3encorafenib 2Tomography, X-Ray Computed 2Sunitinib 2Referral and Consultation 2Radiotherapy 2Practice Guidelines as Topic 2Pemetrexed 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Focus Groups × 1 year × Clear all
NCT06559462 2025-11-25

DPYD Nudges

Abramson Cancer Center at Penn Medicine

Phase NA Completed
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon âš¡